Anti-Retroviral Therapy
Antiretroviral therapy refers to HIV treatment that uses a combination of two or more antiretroviral drugs. Antiretroviral therapy revolutionized HIV treatment upon its introduction in 1996. Antiretroviral therapy is an effective treatment for HIV. It does not cure the condition, but it can reduce the viral load to undetectable levels. This means that the virus is not transmittable through sexual activity and a person's immune system can recover. It usually takes around 3–6 months for the viral load to reach undetectable levels.fatal disease into a manageable chronic condition, it does not cure HIV. Lifelong adherence to ART is necessary to maintain viral suppression and prevent drug resistance, which can arise if therapy is interrupted or if there are insufficient drug levels. ART has significantly improved the prognosis for people with HIV, reducing the rates of opportunistic infections, preventing HIV-related complications, and increasing life expectancy. However, ART is not without challenges. Some patients experience side effects, such as gastrointestinal problems, fatigue, or metabolic changes, and adherence can be difficult due to the complexity of treatment regimens or socioeconomic barriers. Additionally, the emergence of drug-resistant HIV strains remains a concern, requiring careful management of ART regimens to ensure continued efficacy.
Related Conference of Anti-Retroviral Therapy
21st International Conference on Virology, Emerging Diseases & vaccines
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Antimicrobial and Antibacterial Agents
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
Anti-Retroviral Therapy Conference Speakers
Recommended Sessions
- Animal Virology
- Anti-Retroviral Therapy
- Antiviral Drug Discovery and Development
- Bacterial and Fungal Virology
- Clinical and Diagnostic Virology
- Coronavirus (COVID-19)
- Current Focus in Virology Research
- Gastrointestinal viral diseases
- General Virology
- Hepatic viral diseases
- Insect vector and virus epidemiology
- Microbiology
- Molecular and Cellular Virology
- Neurologic viral diseases
- Pediatric Viral Infectious Diseases
- Plant and Agricultural Virology
- Respiratory viral diseases
- STD & HIV/ AIDS and Emerging Viral Diseases
- Viral Immunology
- Viral Oncology
- Viral Vaccines
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical and Neuro Virology - Virology-2026 (UK)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Emerging infectious diseases and the "One Health" concept - Virology-2026 (UK)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2026 (UK)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- General Virology - Virology-2026 (UK)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Immunization and Immunotherapeutics - Virology-2026 (UK)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Influenza and other Respiratory Diseases - Virology-2026 (UK)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Measles as re-emerging infectious disease - Virology-2026 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- New and Endogenous Retroviruses - Virology-2026 (UK)
- Novel Antiviral Therapies - Virology-2026 (UK)
- Novel Vaccine Delivery Methods - Virology-2026 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- STD's and Non-Viral STIs - Virology-2026 (UK)
- Structural and Molecular virology - Virology-2026 (UK)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
- Transmission of Viruses - Virology-2026 (UK)
- Transplant-Associated Viral Infections - Virology-2026 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2026 (UK)
- Vaccines against tropical and neglected diseases - Virology-2026 (UK)
- Vaccines and the Microbiome - Virology-2026 (UK)
- Veterinary virology - Virology-2026 (UK)
- Viral Genetics, Evolution and Dynamics - Virology-2026 (UK)
- Viral Immunology and Immunopathology - Virology-2026 (UK)
- Viral Oncology - Virology-2026 (UK)
- Viral Pathogenesis - Virology-2026 (UK)
